Stereotaxis, Inc. (NASDAQ:STXS) director Arun Menawat has reported a direct acquisition of company common stock, according to a Form 4 filing submitted to the Securities and Exchange Commission. The transaction took place on November 17, 2026.
Menawat purchased 121,561 shares at a price of $0.8225 per share, for a total value of approximately $99,983. As a result of the purchase, his direct holdings in Stereotaxis common stock now stand at 1,157,121 shares. The filing was signed by Kimberly R. Peery, Attorney-in-Fact for Arun S. Menawat, on November 18, 2026.
The disclosure arrives at a time when Stereotaxis shares are trading at $0.95. The stock has declined 45% over the past six months. The company carries a market capitalization of $95.42 million and, according to an analysis, is quickly burning through cash. That analysis also highlights six additional key tips for investors evaluating the medical device maker.
Separately, Stereotaxis recently reported third-quarter earnings that showed a larger-than-expected loss and revenue that fell short of Wall Street forecasts. The company recorded an adjusted loss of $0.07 per share, compared with analysts' expectations of a $0.05 loss. Revenue reached $8.9 million, missing the anticipated $9.93 million, even though it represented a 20% increase from the previous year.
Management highlighted advancements in new products and expressed optimism about achieving profitability in the upcoming year. These developments have been closely watched by investors and analysts alike.
The Form 4 disclosure provides a factual account of the director's direct ownership change. It does not include any statement from Menawat regarding his reasons for the purchase, nor does it offer guidance on future transactions. The filing is a standard regulatory notification of insider activity and should be read alongside the company's broader financial disclosures.
For investors tracking Stereotaxis, the insider purchase and the recent quarterly results represent two distinct data points. The purchase reflects a change in a director's direct holdings, while the earnings report details the company's recent financial performance against analyst expectations. Both are part of the public record available to market participants.